A cost utility analysis for the management of acute exacerbations of chronic rhinosinusitis.
Matthew M ChuJack T GarciaAhmad R SedaghatGeorge A ScangasKatie M PhillipsPublished in: International forum of allergy & rhinology (2024)
Observation is the most cost-effective strategy for the initial management of AECRS when there is a low likelihood of bacterial infection. When the probability of bacterial etiology of AECRS exceeds 49.0%, upfront rescue medications proved to be the most cost-effective strategy.